Gene: CLN8
Official Full Name: CLN8 transmembrane ER and ERGIC proteinprovided by HGNC
Gene Summary: This gene encodes a transmembrane protein belonging to a family of proteins containing TLC domains, which are postulated to function in lipid synthesis, transport, or sensing. The protein localizes to the endoplasmic reticulum (ER), and may recycle between the ER and ER-Golgi intermediate compartment. Mutations in this gene are associated with a disorder characterized by progressive epilepsy with cognitive disabilities (EPMR), which is a subtype of neuronal ceroid lipofuscinoses (NCL). Patients with mutations in this gene have altered levels of sphingolipid and phospholipids in the brain. [provided by RefSeq, Jul 2017]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO00292 | CLN8 Knockout cell line (HeLa) | Human | CLN8 | 1:3~1:6 | Negative | Online Inquiry |
KO37998 | CLN8 Knockout cell line (HCT 116) | Human | CLN8 | 1:2~1:4 | Negative | Online Inquiry |
KO37999 | CLN8 Knockout cell line (HEK293) | Human | CLN8 | 1:3~1:6 | Negative | Online Inquiry |
KO38000 | CLN8 Knockout cell line (A549) | Human | CLN8 | 1:3~1:4 | Negative | Online Inquiry |
CLN8 Gene Knockout Cell Lines are genetically modified cellular systems designed to facilitate the study of the CLN8 gene, which is implicated in various neurodegenerative disorders, including forms of Batten disease. These cell lines are engineered through robust gene-editing technologies, such as CRISPR/Cas9, to disable the expression of the CLN8 gene, thereby allowing researchers to investigate its biological functions and the pathological mechanisms associated with its knockout. The absence of CFN8 facilitates the assessment of cellular pathways affected by its dysfunction, providing critical insights into disease etiology.
The primary mechanism of action involves the disruption of the normal cellular processes that require CLN8 protein, which is known to participate in lipid metabolism and cellular homeostasis. By observing the resulting phenotypic changes in the knockout cell lines, researchers can delineate the specific role of CLN8 in cellular processes such as autophagy, apoptosis, and neurotransmission, enhancing the understanding of its contribution to neuronal health and disease.
The scientific importance of CLN8 Gene Knockout Cell Lines extends to experimental models that mimic the neurodegenerative progression observed in patients, making them invaluable tools in preclinical research. They enable the screening of pharmacological agents or gene therapies aimed at ameliorating the effects of CLN8-related pathologies, thereby facilitating the development of novel therapeutic strategies.
In terms of unique selling points, these cell lines offer precise genetic modifications and reproducibility that many alternative models, such as wild-type or non-modified cells, cannot provide. The specific targeting of the CLN8 gene ensures that researchers are examining a clean system without off-target effects, promoting experimental reliability and data integrity.
For researchers and clinicians focused on neurodegenerative diseases, the CLN8 Gene Knockout Cell Lines represent a critical resource that streamlines investigations and accelerates the pace of discovery. These cell lines not only assist in fundamental research but also pave the way for translational applications in developing innovative therapeutic solutions.
Our company prides itself on its commitment to providing high-quality biological products, backed by a team of experts in genetic engineering and cell biology. We understand the intricacies of scientific research and strive to support your endeavors with advanced tools designed to enhance research outcomes.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.